These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 24696731

  • 1. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
    Li J, Sheng C, Li W, Zheng JH.
    Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
    [Abstract] [Full Text] [Related]

  • 2. Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.
    Yang FQ, Huang JH, Liu M, Yang FP, Li W, Wang GC, Che JP, Zheng JH.
    Int J Clin Exp Pathol; 2014; 7(1):340-7. PubMed ID: 24427355
    [Abstract] [Full Text] [Related]

  • 3. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
    Yan Y, Yang FQ, Zhang HM, Li J, Li W, Wang GC, Che JP, Zheng JH, Liu M.
    Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.
    Li W, Liu M, Feng Y, Xu YF, Che JP, Wang GC, Zheng JH, Gao HJ.
    Int J Clin Exp Pathol; 2013; 6(6):1086-94. PubMed ID: 23696926
    [Abstract] [Full Text] [Related]

  • 5. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
    Yang FQ, Yang FP, Li W, Liu M, Wang GC, Che JP, Huang JH, Zheng JH.
    Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
    [Abstract] [Full Text] [Related]

  • 6. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
    Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC.
    Eur Urol; 2014 Nov; 66(5):929-35. PubMed ID: 24388441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.
    Xue YJ, Xiao RH, Long DZ, Zou XF, Wang XN, Zhang GX, Yuan YH, Wu GQ, Yang J, Wu YT, Xu H, Liu FL, Liu M.
    J Transl Med; 2012 Sep 24; 10():200. PubMed ID: 23006512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.